We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

New Partnership To Develop a Pan-Coronavirus DNA Vaccine

Product News   Apr 29, 2020

 
New Partnership To Develop a Pan-Coronavirus DNA Vaccine

Entos is developing Covigenix, a pan-coronavirus DNA vaccine based on its Fusogenix drug delivery technology. EpiVax will provide optimized epitopes from multiple COVID-19 proteins identified using their proprietary in silico immunogenicity screening technology. Credit: TEC Edmonton.

FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Thermo Fisher Scientific and Q2 Solutions Partner to Deliver Clinical Trial Results Faster

Product News

Q2 Solutions has announced its partnership with Thermo Fisher Scientific to deliver clinical trial lab results economically with unprecedented speed.

READ MORE

Immune Responsive Nanoparticles for COVID-19 Vaccine Delivery

Product News

Analytik reports how the Quadram Institute has invested in a ZetaView Nanoparticle Tracking Analyser to help them develop a new approach for vaccine delivery based on engineering the natural ability of resident gut bacteria to generate nanoparticle sized Outer Membrane Vesicles.

READ MORE

Delta 4 Announces Results Achieved With Drug Discovery Platform

Product News

Delta 4 has announced recent results achieved in two drug discovery and development programs, involving kidney disease and COVID-19.

READ MORE

Like what you just read? You can find similar content on the communities below.

Drug Discovery Genomics Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE